PTK2 and breast cancer: Given that PXDN depletion using siRNA reduced FAK phosphorylation in HUVEC cells, it could be speculated that PXDN expression and/or activity, and FAK signalling may work together to play a role in the invasion of breast cancer cells, although the direct interplay between FAK inhibitors and PXDN expression and activity should be further explored in this setting.